IDH2 and glioma: This finding might be due to the fact that IDH mutation leads to a CpG island methylator phenotype (CIMP) in gliomas, which causes genome-wide extensive DNA hypermethylation [28], likely including hypermethylation of the CpG island 114 in the DIRAS-1 promoter region.